03 June 2026 DOWNLOAD TO YOUR CALENDAR London, U.K. View Conference Website ...
Can brain amyloid reduction be used as a surrogate biomarker of clinical benefit? This is a hotly debated question in the field (see Dec 2024 discussion). A recent post hoc analysis of Phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results